Definitive Contract 75F40124C00132
Award Date
9/12/24
Potential Completion Date
9/29/26
Potential Value
$460K
Federal Agency
Food and Drug Administration
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
PSC Category
R499 - Support- Professional: Other
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Baltimore, MD 21201, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $669,734.24, was issued by the Food and Drug Administration (FDA) to the University of Maryland, Baltimore (UMB) to provide NONDESTRUCTIVE ANALYTICS FOR VACCINES. The contract is a definitive, firm fixed-price agreement, with a period of performance through March 29, 2024. UMB, the prime contractor, is a major public research university and the founding campus of the University System of Maryland (USM). The contract does not have a set-aside designation....
This is a $85,000 firm fixed price purchase order contract awarded by the Bureau of Medicine and Surgery, a defense agency, to the University of Maryland, Baltimore (UMB). The contract has a base year period of performance ending on September 14, 2022 and was awarded on September 11, 2020 with no set-aside designation. UMB, which serves as the prime contractor, is a major public research university that frequently receives federal contract and grant awards to support its biomedical research,...
This is a $164,509.80 firm fixed price contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to the University of Maryland, Baltimore (UMB) for MS research services. The contract has a performance period through November 30, 2024. UMB is conducting the research as the prime contractor, with no set-aside designation noted. The University System of Maryland (USM) is the parent organization providing institutional support to UMB. UMB has a track record of...
This is a definitive federal contract awarded by the Department of Health and Human Services' National Institutes of Health to the University of Maryland, Baltimore (UMB) for an Adjuvant Development Program. The $7,110,426.96 contract has a period of performance through September 29, 2024 and uses a cost no fee pricing type. UMB is the prime contractor, and the contract is not set aside for any specific business category. The contract supports biomedical research and product development, with...
This is a firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to the University of Maryland, Baltimore (UMB) for $81,744.84. The contract is for biomedical research and does not have a set-aside designation. UMB, which is a major public research university and academic health institution, often serves as a prime contractor on federal contracts and grants to support its research, education, and clinical activities. This award is part of UMB's broader...
This is a federal contract award to the University of Maryland, Baltimore (UMB), a major public research university, for biomedical research and services. The $510,342.33 definitive contract was awarded on December 13, 1996 by the National Institutes of Health (NIH), a civilian agency, with a period of performance through December 31, 2005. The contract has a "Cost No Fee" pricing type, and was not set aside for any special business category. UMB, the prime contractor, provides a...
This is a $80,529 firm fixed price contract awarded by the Department of Veterans Affairs (VA) to the University of Maryland, Baltimore (UMB) for laboratory work and research and development services. The contract has no set-aside designation. UMB, a major public research university, often serves as the prime contractor on federal contracts and grants, leveraging its expertise in biomedical research, healthcare, and other disciplines to support various government agencies. The University...
This is a firm fixed price purchase order contract awarded by the Office of Logistics and Acquisition Operations, a civilian agency, to the University of Maryland, Baltimore (UMB) for mass spectrometry services in support of ongoing projects. The contract has a ceiling value of $32,870.00 and a performance period ending on August 30, 2022. UMB, which operates as the Baltimore Campus, is a public research university and major recipient of federal funding through contracts and grants. The...
This is a firm fixed price purchase order contract awarded by the Food and Drug Administration (FDA) to the University of Maryland, Baltimore (UMB) for $204,840.00. The contract is for "PATIENT RECRUITMENT VR-TB" and does not have a set-aside designation. UMB, a major public research university, frequently receives federal contracts and grants to support its research, education, and clinical activities. The contract award is associated with an originating special notice posted by the...
This is a $879,424.00 firm fixed-price service agreement contract awarded by the U.S. Army Research, Development and Engineering Command (RDECOM) to the University of Maryland, Baltimore (UMB) on February 28, 2017. The contract has a base year period of performance ending on February 28, 2020, with no set-aside designation. UMB is providing services under this contract, which is part of a larger $6 million Blanket Purchase Agreement with the Department of Veterans Affairs for reagents, supplies,...